Iopamiro相關文獻

Iopamiro 優點相關文獻

 

Laskey W1, Aspelin P, Davidson C, Rudnick M, Aubry P, Kumar S, Gietzen F, Wiemer M; DXV405 Study Group. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J. 2009 Nov;158(5):822-828.e3. doi: 10.1016/j.ahj.2009.08.016.

www.ncbi.nlm.nih.gov/pubmed/?term=Am+Heart+J.+2009+Nov%3B158(5)%3A822-828

 

Bedolla-Barajas M1, Hernández-Colín DD, Morales-Romero J, Serrano-Salinas C. Immediate and nonimmediate reactions induced by contrast media: incidence, severity and risk factors. Asia Pac Allergy. 2013 Oct;3(4):241-8. doi: 10.5415/apallergy.2013.3.4.241. Epub 2013 Oct 31.

www.ncbi.nlm.nih.gov/pubmed/?term=Asia+Pac+Allergy.+2013+Oct%3B3(4)%3A241-8

 

Kondo T1, Kumamaru KK, Fujimoto S, Matsutani H, Sano T, Takase S, Rybicki FJ. Prospective ECG-gated coronary 320-MDCT angiography with absolute acquisition delay strategy for patients with persistent atrial fibrillation. AJR Am J Roentgenol. 2013 Dec;201(6):1197-203. doi: 10.2214/AJR.12.10140.

www.ncbi.nlm.nih.gov/pubmed/24261357

 

Drugová B. [Personal experience with iopamidol (Iopamiro) in angiographic and arthrographic diagnosis]. Cesk Radiol. 1986 Oct;40(5):323-8.

www.ncbi.nlm.nih.gov/pubmed/?term=Cesk+Radiol.+1986+Oct%3B40(5)%3A323-8.

 

Bohutova J, Kolar J, Lerlova L, Fendrych P. Experience with iopamidol in myeloradiculography. Eur J Radiol. 1985 Feb;5(1):77-80.

www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Radiol.+1985+Feb%3B5(1)%3A77-80.

 

Kónya A, Kovács K, Vadon G. [Experiences with a new hyperosmolar contrast medium Iopamiro, Bracco in peripheral arteriography]. Radiol Diagn (Berl). 1985;26(2):277-83.

www.ncbi.nlm.nih.gov/pubmed/?term=Radiol+Diagn+(Berl).+1985%3B26(2)%3A277-83.

 

Andreucci M, Faga T, Pisani A, Sabbatini M, Russo D, Michael A. Prevention of Contrast-Induced Nephropathy through a Knowledge of Its Pathogenesis and Risk Factors. ScientificWorldJournal. 2014;2014:823169.

www.ncbi.nlm.nih.gov/pubmed/25525625

 

Akyıldız Akçay F, Bayata S, Semerci T, Yeşil M, Toklu O, Arıkan E, Yakar Tülüce S, Köseoğlu M, Koçağra Yağız I. The effects of iodixanol and iopamidol on adhesion molecule serum levels in patients with angina pectoris undergoing coronary angiography: a randomized study. Anadolu Kardiyol Derg. 2014 Mar;14(2):156-61

www.ncbi.nlm.nih.gov/pubmed/?term=The+effects+of+iodixanol+and+iopamidol+on+adhesion+molecule+serum+levels+in+patients+with+angina+pectoris+undergoing+coronary+angiography%3A+a+randomized+study

 

Weiland FL, Marti-Bonmati L, Lim L, Becker HC. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial. Acta Radiol. 2014 Jul;55(6):715-24.

www.ncbi.nlm.nih.gov/pubmed/24060817.

 

Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006 Nov;41(11):815-21.

www.ncbi.nlm.nih.gov/pubmed/17035872

 

Suga K, Karino Y, Fujita T, Okada M, Kawakami Y, Ueda K, Yuan Y, Matsunaga N. Cutaneous drainage lymphatic map with interstitial multidetector-row computed tomographic lymphography using iopamidol: preliminary results.  Lymphology. 2007 Jun;40(2):63-73

www.ncbi.nlm.nih.gov/pubmed/17853616

 

Ozbulbul NI, Yurdakul M, Tola M. Comparison of a low-osmolar contrast medium, iopamidol, and an iso-osmolar contrast medium, iodixanol, in MDCT coronary angiography. Coron Artery Dis. 2010 Nov;21(7):414-9.

www.ncbi.nlm.nih.gov/pubmed/20671550

 

Christensen JD, Meyer LT, Hurwitz LM, Boll DT. Effects of iopamidol-370 versus iodixanol-320 on coronary contrast, branch depiction, and heart rate variability in dual-source coronary MDCT angiography.  AJR Am J Roentgenol. 2011 Sep;197(3):W445-51.

www.ncbi.nlm.nih.gov/pubmed/21862771

 

Kumamaru KK, Steigner ML, Soga S, Signorelli J, Bedayat A, Adams K, Mitsouras D, Rybicki FJ. Coronary enhancement for prospective ECG-gated single R-R axial 320-MDCT angiography: comparison of 60- and 80-mL iopamidol 370 injection. AJR Am J Roentgenol. 2011 Oct;197(4):844-50.

www.ncbi.nlm.nih.gov/pubmed/21940571

 

Spataro RF, Fischer HW, Boylan L. Urography with low-osmolality contrast media: comparative urinary excretion of Iopamidol, Hexabrix, and diatrizoate. Invest Radiol. 1982 Sep-Oct;17(5):494-500.

www.ncbi.nlm.nih.gov/pubmed/7141831

 

Widrich WC, Robbins AH, Rommel AJ, Andrews R. Iopamidol: a non-ionic contrast agent for peripheral arteriography. Radiology. 1982 Oct;145(1):53-5

www.ncbi.nlm.nih.gov/pubmed/7122896

 

Mills SR, Wertman DE Jr, Heaston DK, Moore AV Jr, Bates M, Allen S, Rommel AJ, Thompson WM. Study of safety and tolerance of iopamidol in peripheral arteriography. Radiology. 1982 Oct;145(1):57-8.

www.ncbi.nlm.nih.gov/pubmed/7122897

 

Hagen B. [Iopamidol, a new non-ionic roentgen contrast medium. Results of angiographic studies in more than 300 patients, with special reference to pain reactions]. Radiologe. 1982 Dec;22(12):581-5. German

www.ncbi.nlm.nih.gov/pubmed/7156393

 

Kallehauge HE, Praestholm J. Iopamidol, a new nonionic contrast medium in peripheral angiography. Cardiovasc Intervent Radiol. 1982;5(6):325-8.

www.ncbi.nlm.nih.gov/pubmed/6762926

 

Selin K, Wallin J, Björk L. Coronary angiography with Iopamidol. Acta Radiol Diagn (Stockh). 1982;23(6):545-8.

www.ncbi.nlm.nih.gov/pubmed/6763455

 

Bacarini L, de Nicola T, Gasparini D, Orlando P, Vassallo A. Iopamidol (B 15000), a nonionic water-soluble contrast medium for neuroradiology. Part I: Results of a clinical trial for myelography. Neuroradiology. 1982;23(2):81-4.

www.ncbi.nlm.nih.gov/pubmed/7043305

 

Dalla Palma L, Rossi M, Stacul F, Agostini R. Iopamidol in urography. A comparison between ionic and nonionic contrast media in patients with normal and impaired renal function.  Urol Radiol. 1982;4(1):1-3.

www.ncbi.nlm.nih.gov/pubmed/7101596

 

Bassi P, Cecchini A, Dettori P, Signorini E. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications. Neuroradiology. 1982;24(2):85-90.

www.ncbi.nlm.nih.gov/pubmed/7177375

 

Bonati F, Felder E, Tirone P. Iopamidol: new preclinical and clinical data. Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S310-6.

www.ncbi.nlm.nih.gov/pubmed/7203941

 

Caputo N, Chiurulla C, Cianciulli E, Ciorba E, Floridi P, Pelliccioli GP, Capponi O, Signorini E. [Sacroradiculo graphic and myelographic investigations with iopamidol: study of 610 examinations (author's transl)]. Riv Patol Nerv Ment. 1981 Mar-Apr;102(2):56-68

www.ncbi.nlm.nih.gov/pubmed/7345552

 

Partridge JB, Robinson PJ, Turnbull CM, Stoker JB, Boyle RM, Morrison GW. Clinical cardiovascular experiences with iopamidol: a new non-ionic contrast medium. Clin Radiol. 1981 Jul;32(4):451-5.

www.ncbi.nlm.nih.gov/pubmed/6972848

 

Bianchi SD, Granone A, Gatti G, Mecozzi B, Andretta L. Renal contrastography with rapid intravenous injection of Iopamidol]. Radiol Med. 1981 Sep;67(9):668-9.

www.ncbi.nlm.nih.gov/pubmed/7313186

 

Hammer B, Lackner W. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology. Neuroradiology. 1980 Apr;19(3):119-21.

www.ncbi.nlm.nih.gov/pubmed/6991972

 

Corsi M, Moretti C, Biasizzo P.  [First results by means of non-ionic contrast medium (Iopamidol) in urography and angiography (author's transl)].  Radiol Med. 1980 Apr;66(4):215-8

www.ncbi.nlm.nih.gov/pubmed/7005986

 

Pitrè D, Felder E. Development, chemistry, and physical properties of iopamidol and its analogues. Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S301-9.

www.ncbi.nlm.nih.gov/pubmed/7203940

聯絡我們

普樂可醫藥股份有限公司 地址 : 台北市民生東路一段58號11樓 電話 : (02) 2521-0566
傳真 : (02) 2571-0157
p5418173@ms17.hinet.net